Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Dialysis industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Product & service trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Dialysis Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
3.2.1.2 Increasing incidence of diabetes
3.2.1.3 Shortage of donor kidneys
3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
3.2.1.5 R&D investments in developed as well as developing countries
3.2.2 Industry pitfalls & challenges
3.2.2.1 Product recalls
3.2.2.2 Complications in the treatment
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By product & services
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.5.3 Asia Pacific
3.6 Reimbursement scenario
3.7 Value chain analysis
3.8 Future market trends
3.9 Technology landscape
3.10 Porter's analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive Positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Dialysis Market, By Type
5.1 Key type trends
5.2 Hemodialysis
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Peritoneal Dialysis
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Dialysis Market, By Product and Services
6.1 Key product and services trends
6.2 Equipment
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.2 Dialysis machines
6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.3 Water treatment systems
6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.2.4 Others
6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Consumables
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.2 Dialyzers
6.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.3 Catheters
6.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.4 Access products
6.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.5 Concentrates
6.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3.6 Others
6.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Services
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.2 Acute dialysis
6.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4.3 Chronic dialysis
6.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Dialysis Market, By End-use
7.1 Key end-use trends
7.2 In-center dialysis
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Home dialysis
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Dialysis Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Sapin
8.3.5 Italy
8.3.6 Poland
8.3.7 Sweden
8.3.8 Netherlands
8.3.9 Germany
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Malaysia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Chile
8.5.5 Colombia
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Turkey
8.6.6 Egypt
Chapter 9 Company Profiles
9.1 B. Braun Holding GmbH & Co. KG
9.2 AngioDynamics, Inc.
9.3 Baxter International Inc.
9.4 Fresenius SE and Co. KGaA
9.5 Becton, Dickinson and Company
9.6 Medtronic Plc.
9.7 Nikkiso Co. Ltd.
9.8 Teleflex Incorporated
9.9 Nipro Medical Corporation
9.10 DaVita Inc.
9.11 Dialife SA
9.12 Asahi Kasei Corporation
9.13 JMS Co Ltd
9.14 KAWASUMI LABORATORIES INC
9.15 Rogosin Institute
9.16 Satellite Healthcare
9.17 Toray Industries Inc.
9.18 U.S. Renal Care, Inc.
